Carol Pollock

Australian nephrologist and medical researcher
The basics

Quick Facts

IntroAustralian nephrologist and medical researcher
A.K.A.Carol Anne Pollock Carol A. Pollock Carol A Pollock
A.K.A.Carol Anne Pollock Carol A. Pollock Carol A Pollock
PlacesAustralia
isPhysician Nephrologist Researcher Medical researcher
Work fieldHealthcare
Gender
Female
Education
University of SydneySydney, New South Wales, AustraliaDoctor of Philosophy
Employers
University of SydneySydney, New South Wales, Australia
Awards
Officer of the Order of Australia2021
Fellow of the Australian Academy of Health and Medical Sciences2015
The details

Biography

Carol Pollock AO FAHMS is a medical researcher specialising in kidney health and disease. She is a Clinical Professor of Medicine at the University of Sydney, Northern Clinical School, Kolling Institute of Medical Research. Her research interests also include obesity, diabetes, cardiovascular disease, healthy ageing and lifespan, employing animal models and cellular and molecular techniques. She is the Chair of Kidney Health Australia and was the Chair of Medicine Royal North Shore Hospital in 2011 to 2016.

Awards and recognition

Pollock was awarded the Officer of the Order of Australia on 14 June 2021 for 'distinguished service to medical research, education and science, to nephrology, and to clinical practice and governance.'

In 2015, she was elected as a fellow of Australian Academy of Health and Medical Sciences.

Selected publications

  • Koshino, A., Mahaffey, K., Pollock, C., Hansen, M., Wada, T., Heerspink, H., Neuen, B., Oshima, M., Toyama, T., Hara, A., Jardine, M., et al (2024). Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial. Kidney International Reports, 9(2), 347-355.
  • Kolovos, P., Pollock, C. (2024). Diabetic kidney disease A new era in therapeutic management. Medicine Today, 25(1-2), 47-51.
The contents of this page are sourced from Wikipedia article on 02 Oct 2024. The contents are available under the CC BY-SA 4.0 license.